Trial design
This was a two-stage study (Fig. Consort flow diagram. Numbers of patients allocated through pre-screening, consent, leukapheresis and Stage I and II of the study. In Stage I, patients were randomised to receive two cycles of DCV (Arm 1) or two cycles of DCV + 